Diebold Nixdorf, Incorporated reported $3.86B of revenue over the trailing twelve months, +4.3% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $3.86B (to Q1 2026). Net Income: $108M, trailing twelve months to Q1 2026. Op Margin: 6.3%, trailing twelve months to Q1 2026. EPS: $2.92, trailing twelve months to Q1 2026.

DBDDiebold Nixdorf, Incorporated

TechnologyUSD

$67.80

$54.9052 weeks$90.72

DBD as reported

Diebold Nixdorf, Incorporated reported $3.86B of revenue over the trailing twelve months, +4.3% on the year before. 10 reported series are charted on this page, each one as filed.

$3.86B

Revenue, trailing twelve months · to Q1 2026 · +4.3% against the twelve months before

Net Income: $108M
Net Income · −1158% year on year · trailing twelve months to Q1 2026
Op Margin: 6.3%
Op Margin · trailing twelve months to Q1 2026
EPS: $2.92
EPS · −1181% year on year · trailing twelve months to Q1 2026

Every series Ryufin has for DBD, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$3.86B	+4.3%	Q1 2026
Net Income	$108M	−1158%	Q1 2026
EPS	$2.92	−1181%	Q1 2026
Gross Margin	25%	n/a	Q1 2026
Op Margin	6.3%	n/a	Q1 2026
Net Margin	2.7%	n/a	Q1 2026
ROE	5.6%	n/a	Q1 2026
ROA	1.6%	n/a	Q1 2026
ROIC	9.9%	n/a	Q1 2026
Free Cash Flow	−$23M	n/a	Q4 2020 · 21 quarters behind